Skip to content

Released Nov 8, 2017, before the open

10-Q filed Nov 8, 2017, 39 days after period end · 0001144204-17-057030

Q3 2017 · 10-Q
Revenue$0.00no prior Q3 2016 on fileno prior Q2 2017 on file
Net Income-$4.70MN/M vs Q3 2016N/M vs Q2 2017
EPS Diluted-$0.22N/M vs Q3 2016N/M vs Q2 2017
Operating Income-$4,766,059N/M
Operating Cash Flowderived-$4,565,753N/M
Free Cash Flowderived-$4,565,753N/M

What the release said

The release

Same quarter

MetricQ3 2017Q3 2016Q3 2015Q3 2014
Revenue$0.00———
Net Income-$4.70M-$3.24M-$6.37M-$4.09M
EPS Diluted-$0.22-$0.18-$0.35-$0.32

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR